HealthRecordCommunity
FHIRHL7🌏 InternationalEnriched

Clinical Trial Analytics: From Patient Recruitment to Evidence-Based Innovation

臨床試験のデータ分析:患者募集から根拠に基づくイノベーションへ

August 22, 2026

Summary

This article explains that clinical trial data analytics is crucial for moving beyond simple dashboards, providing real-time, actionable insights to support research. Specifically, utilizing standards like FHIR and OMOP makes it possible to transform fragmented healthcare data into governed intelligence.

Details

Clinical trials generate vast amounts of diverse data—including EHR records, lab results, claims, and registries—but this data is often fragmented, inconsistently coded, and difficult to use. Strategic data analytics is needed to address this challenge. The goal is not merely answering a reporting query like “How many patients do we have?” but rather determining “How many patients meet this exact clinical definition, at the right point in their care journey, based on trustworthy data?” This requires clinical context, terminology normalization, longitudinal processing, and temporal logic. FHIR provides a structured way to exchange clinical data between healthcare systems. Projects like HL7 Vulcan’s Real World Data initiative show how FHIR can support research-relevant data retrieval from EHR systems. OMOP CDM plays an important role by standardizing observational healthcare data for analysis across datasets and institutions. While these standards provide the foundation, further effort is needed to make the data ready for trial decisions. It is highlighted that slow patient recruitment is often not just an outreach problem, but a data usability problem. By leveraging FHIR and OMOP, it becomes possible to connect clinical care data with research analytics, thereby building a foundation of reliable, computable cohorts.

📰
Read Original Article
orldhealth.net
→

Original content copyright by respective publishers